Cargando…
Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.
Topoisomerase II is a key target for many anti-cancer drugs used to treat breast cancer. In human cells there are two closely related, but differentially expressed, topoisomerase II isoforms, designated topoisomerase II alpha and beta. Here, we report the production of a new polyclonal antibody rais...
Autores principales: | Houlbrook, S., Addison, C. M., Davies, S. L., Carmichael, J., Stratford, I. J., Harris, A. L., Hickson, I. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034103/ https://www.ncbi.nlm.nih.gov/pubmed/8519659 |
Ejemplares similares
-
Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
Publicado: (1996) -
The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues.
por: Turley, H., et al.
Publicado: (1997) -
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors.
por: Davies, S. L., et al.
Publicado: (1997) -
Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.
por: Kirk, J., et al.
Publicado: (1993) -
Topoisomerase II isoforms are required for HIV-1 reverse transcription
por: Sunnam, Lokeswara Balakrishna, et al.
Publicado: (2012)